Locally Recurrent Breast Cancer
📧 Sign up to get email alerts when something new happens for Locally Recurrent Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer [Phase 1]
This clinical trial update reports on Z-Endoxifen Hydrochloride being studied for estrogen receptor-positive breast cancer that is metastati…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating a photo-medicine-guided dual approach for reoperation of sentinel lymph nodes in locally recurrent …
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 pivotal study in HER2-negative locally recurrent or metastatic breast cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Revisiting Omental Transposition in Locally Advance and Locally Recurrent Breast Cancer
Clinical trial evaluating omental transposition for locally advanced and locally recurrent breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer [Phase 2]
Phase 2 trial of lapatinib with radiation therapy for locally advanced or locally recurrent breast cancer; the study was terminated with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating single-agent eribulin mesylate as first-line therapy for locally recurrent or metastatic HER2-negative breast can…
-
CLINICAL_TRIALS research · 2016-06-30Clinical Trial Update: An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)
An observational study (VIRGO) assessing treatment patterns and safety outcomes in metastatic or locally recurrent breast cancer. The study …
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [NA]
A completed bioequivalence study comparing IG-001 to nab-paclitaxel in metastatic or locally recurrent breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating imetelstat in combination with paclitaxel, with or without bevacizumab, in locally recurrent or metastatic breast…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. [Phase 3]
A Phase 3 clinical trial evaluating Avastin (bevacizumab) plus taxane-based therapy for locally recurrent or metastatic breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating adjuvant chemotherapy after surgical resection for relapsed or locally recurrent breast cancer; results we…